Healthcare has become the second-best performer in the S&P 500 (SP500) this month, prompting market observers to foresee a ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Evaxion Biotech (EVAX – Research Report) and ...

Healthcare stocks can be a great investment. Stocks in the healthcare sector, which are holistically represented by the Health Care Select Sector SPDR ETF (XLV), have broadly outperformed the ...

Eli Lilly (NYSE: LLY) sells many products across treatment areas, from immunology to neuroscience. The company sells ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Here’s a list of buy/sell recommendations for today from analysts: Raja Venkatraman, Ankush Bajaj, and MarketSmith India.

GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth. See why I rate GEHC stock as a buy.

Investing in healthcare stocks has perhaps never been a better idea. The healthcare sector has grown significantly since the start of 2020, aided in large part by increased medical spending during ...